Clemens J D, van Loon F F, Rao M, Sack D A, Ahmed F, Chakraborty J, Khan M R, Yunus M, Harris J R, Svennerholm A M
International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Am J Epidemiol. 1992 Apr 15;135(8):865-74. doi: 10.1093/oxfordjournals.aje.a116382.
The authors estimated the incidence rates of cholera and death between 1985 and 1988 for 32,642 age- and sex-eligible persons who did not participate in a randomized, placebo-controlled field trial of killed oral cholera vaccines in rural Bangladesh. As compared with 20,744 placebo recipients, the relative risk of cholera for all nonparticipants, adjusted for potentially confounding demographic variables, was 1.20 (95% confidence interval (CI) 1.03-1.41); this adjusted relative risk reflected elevated adjusted relative risks in nonparticipants who were medically ineligible (RR = 1.65; 95% CI 1.22-2.22) or refused to participate (RR = 1.19; 95% CI 1.01-1.41), but not in persons absent at the time of vaccination (RR = 1.00; 95% CI 0.78-1.28). The adjusted relative risk of death was also elevated in nonparticipants as compared with placebo recipients (RR = 1.28; 95% CI 1.10-1.48), with the same pattern of adjusted relative risks for different categories of nonparticipants: for ineligible subjects, 2.64 (95% CI 2.12-3.29); for refusers, 1.20 (95% CI 1.02-1.41); and for absentees, 0.95 (95% CI 0.75-1.22). The authors concluded that nonparticipation was associated with clinically cogent adverse health outcomes, but that the magnitude of these associations varied according to the reason for nonparticipation. These findings underscore the caution required in assessing vaccine efficacy with controls who are not vaccinated because of choices made by patients or vaccinators.
作者估算了1985年至1988年期间,孟加拉国农村地区32,642名符合年龄和性别的人群中霍乱发病率和死亡率,这些人未参与口服霍乱死疫苗的随机、安慰剂对照现场试验。与20,744名接受安慰剂者相比,在对潜在混杂人口统计学变量进行调整后,所有未参与者患霍乱的相对风险为1.20(95%置信区间[CI] 1.03 - 1.41);这种调整后的相对风险反映出,在医学上不符合条件的未参与者(RR = 1.65;95% CI 1.22 - 2.22)或拒绝参与者(RR = 1.19;95% CI 1.01 - 1.41)中,调整后的相对风险升高,但在接种时不在场的人群中未升高(RR = 1.00;95% CI 0.78 - 1.28)。与接受安慰剂者相比,未参与者调整后的死亡相对风险也升高(RR = 1.28;95% CI 1.10 - 1.48),不同类别的未参与者调整后的相对风险模式相同:不符合条件的受试者为2.64(95% CI 2.12 - 3.29);拒绝者为1.20(95% CI 1.02 - 1.41);不在场者为0.95(95% CI 0.75 - 1.22)。作者得出结论,未参与与临床上明显的不良健康后果相关,但这些关联的程度因未参与的原因而异。这些发现强调了在评估疫苗效力时,对于因患者或接种者的选择而未接种疫苗的对照组需要谨慎。